Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Halstead 824, Baltimore, MD, 21287, USA.
International Infection Control Program, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Antimicrob Resist Infect Control. 2024 Apr 26;13(1):47. doi: 10.1186/s13756-024-01400-w.
The burden of antimicrobial resistance (AMR) in Latin America is high. Little is known about healthcare workers' (HCWs) knowledge, attitudes, and perceptions of antimicrobial stewardship (AS), AMR, and antibiotic use (AU) in the region.
HCWs from 42 hospitals from 5 Latin American countries were invited to take an electronic, voluntary, anonymous survey regarding knowledge, attitudes, and perceptions of AS, AMR, and AU between March-April 2023.
Overall, 996 HCWs completed the survey (52% physicians, 32% nurses, 11% pharmacists, 3% microbiologists, and 2% "other"). More than 90% of respondents indicated optimizing AU was a priority at their healthcare facility (HCF), 69% stated the importance of AS was communicated at their HCF, and 23% were unfamiliar with the term "antibiotic stewardship". Most (> 95%) respondents acknowledged that appropriate AU can reduce AMR; however, few thought AU (< 30%) or AMR (< 50%) were a problem in their HCF. Lack of access to antibiogram and to locally endorsed guidelines was reported by 51% and 34% of HCWs, respectively. Among prescribers, 53% did not consider non-physicians' opinions to make antibiotic-related decisions, 22% reported not receiving education on how to select antibiotics based on culture results and 60% stated patients and families influence their antibiotic decisions.
Although HCWs perceived improving AU as a priority, they did not perceive AU or AMR as a problem in their HCF. AS opportunities include improved access to guidelines, access to AMR/AU data, teamwork, and education on AS for HCWs and patients and families.
拉丁美洲的抗菌药物耐药性(AMR)负担很重。关于该地区医护人员(HCWs)对抗菌药物管理(AS)、AMR 和抗生素使用(AU)的知识、态度和看法知之甚少。
2023 年 3 月至 4 月,邀请来自拉丁美洲 5 个国家的 42 家医院的 HCWs 参加一项关于 AS、AMR 和 AU 的知识、态度和看法的电子、自愿、匿名调查。
共有 996 名 HCWs 完成了调查(52%为医生,32%为护士,11%为药剂师,3%为微生物学家,2%为“其他”)。超过 90%的受访者表示优化 AU 是他们医疗机构的优先事项,69%表示 AS 的重要性在他们的医疗机构得到传达,23%不熟悉“抗生素管理”一词。大多数(>95%)受访者承认适当的 AU 可以减少 AMR;然而,只有少数人认为 AU(<30%)或 AMR(<50%)是他们医疗机构的问题。分别有 51%和 34%的 HCWs 报告说他们无法获得药敏试验报告和当地认可的指南。在开处方者中,53%的人不认为非医师的意见对抗生素相关决策有影响,22%的人报告说他们没有接受过根据培养结果选择抗生素的教育,60%的人表示患者和家属会影响他们的抗生素决策。
尽管 HCWs 认为改善 AU 是当务之急,但他们并不认为 AU 或 AMR 是他们医疗机构的问题。AS 的机会包括改善获取指南、获取 AMR/AU 数据、团队合作以及为 HCWs 和患者及家属提供 AS 教育。